These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9892209)

  • 21. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
    Chow L; Rezmann L; Imamura K; Wang L; Catt K; Tikellis C; Louis WJ; Frauman AG; Louis SN
    Prostate; 2008 May; 68(6):651-60. PubMed ID: 18288685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation.
    Manna PR; Chandrala SP; Jo Y; Stocco DM
    J Mol Endocrinol; 2006 Aug; 37(1):81-95. PubMed ID: 16901926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone synergizes with non-cyclic AMP pathways to activate the cyclic AMP response element.
    Murrills RJ; Andrews JL; Samuel RL; Coleburn VE; Bhat BM; Bhat RA; Bex FJ; Bodine PV
    J Cell Biochem; 2009 Apr; 106(5):887-95. PubMed ID: 19180574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
    Deeble PD; Murphy DJ; Parsons SJ; Cox ME
    Mol Cell Biol; 2001 Dec; 21(24):8471-82. PubMed ID: 11713282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor induction of cellular proliferation and protooncogene expression in growth-arrested rat H4IIE hepatoma cells: role of cyclic adenosine monophosphate.
    Squinto SP; Block AL; Doucet JP
    Mol Endocrinol; 1989 Mar; 3(3):433-46. PubMed ID: 2546062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor.
    Merkle D; Hoffmann R
    Cell Signal; 2011 Mar; 23(3):507-15. PubMed ID: 20813184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computation of restoration of ligand response in the random kinetics of a prostate cancer cell signaling pathway.
    Dana S; Nakakuki T; Hatakeyama M; Kimura S; Raha S
    Comput Methods Programs Biomed; 2011 Jan; 101(1):1-22. PubMed ID: 20494471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell lines.
    Lieberman MD; Paty P; Li XK; Naama H; Evoy D; Daly JM
    Surgery; 1996 Aug; 120(2):354-9. PubMed ID: 8751604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of aromatase activity by growth factors in an androgen sensitive human prostate cancer cell line, LNCaP.
    Block JL; Block NL; Lokeshwar BL
    Cancer Lett; 1996 Apr; 102(1-2):167-72. PubMed ID: 8603365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP.
    Caraglia M; Di Gennaro E; Barbarulo D; Marra M; Tagliaferri P; Abbruzzese A; Budillon A
    FEBS Lett; 1999 Mar; 447(2-3):203-8. PubMed ID: 10214946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of mitogen-activated protein kinase by ethanol in embryonic liver cells.
    Reddy MA; Shukla SD
    Biochem Pharmacol; 1996 Mar; 51(5):661-8. PubMed ID: 8615903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of inducible cAMP early repressor (ICER) is altered in prostate cancer cells and reverses the transformed phenotype of the LNCaP prostate tumor cell line.
    Yehia G; Razavi R; Memin E; Schlotter F; Molina CA
    Cancer Res; 2001 Aug; 61(16):6055-9. PubMed ID: 11507053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential signaling cascade of MAP kinase and S6 kinase depends on 3',5'-monophosphate concentration in schwann cells: correlation to cellular differentiation and proliferation.
    Mutoh T; Li M; Yamamoto M; Mitsuma T; Sobue G
    Brain Res; 1998 Nov; 810(1-2):274-8. PubMed ID: 9813365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line.
    Cox ME; Deeble PD; Bissonette EA; Parsons SJ
    J Biol Chem; 2000 May; 275(18):13812-8. PubMed ID: 10788503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer.
    Singh R; Meng H; Shen T; Lumahan LEV; Nguyen S; Shen H; Dasgupta S; Qin L; Karri D; Zhu B; Yang F; Coarfa C; O'Malley BW; Yi P
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2218229120. PubMed ID: 37155905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells.
    Gao Z; Lei WI; Lee LTO
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of COX-2, HER-2/neu and E-Cadherin protein expression in the prostatic adenocarcinoma: preliminary findings.
    Musalam A; Andarawi M; Osman M; Al-Shriam M; Elrefaie A; Mahfouz AA; Hussein MA
    Am J Transl Res; 2019; 11(3):1653-1667. PubMed ID: 30972191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways.
    Ma M; Dai J; Tang H; Xu T; Yu S; Si L; Cui C; Sheng X; Chi Z; Mao L; Wu X; Yang L; Yu H; Li S; Lian B; Tang B; Wang X; Yan X; Bai X; Zhou L; Kong Y; Guo J
    Theranostics; 2019; 9(4):945-960. PubMed ID: 30867808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate Cancer.
    Huan T; Troyer DA; Li L
    Sci Rep; 2016 Aug; 6():32272. PubMed ID: 27578275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.
    Berruti A; Vignani F; Russo L; Bertaglia V; Tullio M; Tucci M; Poggio M; Dogliotti L
    Open Access J Urol; 2010 Jul; 2():109-24. PubMed ID: 24198620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.